Medical Technology - Jordan

  • Jordan
  • In 2024, it is projected that the revenue in the Medical Technology market market in Jordan will reach US$430.40m.
  • Among the various markets within the market, the largest one is Medical Devices, which is expected to have a market volume of US$362.60m in the same year.
  • Looking ahead, the revenue is anticipated to display an annual growth rate (CAGR 2024-2029) of 5.02%, leading to a market volume of US$549.90m by 2029.
  • When compared globally, the United States is expected to generate the highest revenue in the Medical Technology market market, reaching US$210.00bn in 2024.
  • Jordan's medical technology market is experiencing a surge in innovative healthcare solutions, driving advancements in telemedicine and remote patient monitoring.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Jordan has been experiencing steady growth in recent years, driven by customer preferences for advanced healthcare solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Medical Technology market in Jordan have been shifting towards more advanced and innovative healthcare solutions. Patients are increasingly seeking out medical devices and technologies that offer higher accuracy, efficiency, and convenience. This has led to a growing demand for state-of-the-art diagnostic equipment, telemedicine solutions, wearable devices, and robotic-assisted surgical systems. The preference for these advanced technologies is driven by the desire for better healthcare outcomes and improved patient experience. One of the key trends in the Medical Technology market in Jordan is the adoption of digital health solutions. The increasing penetration of smartphones and internet connectivity has enabled the development and adoption of telemedicine platforms, remote patient monitoring systems, and mobile health applications. These digital health solutions are transforming the way healthcare is delivered, making it more accessible and convenient for patients, especially those in remote areas. The trend towards digital health is expected to continue as the government and healthcare providers invest in infrastructure and policies to support its growth. Another trend in the Medical Technology market in Jordan is the focus on personalized medicine. Advances in genomics and molecular diagnostics have made it possible to tailor medical treatments to individual patients based on their genetic makeup. This personalized approach to healthcare is gaining popularity as it offers the potential for more effective and targeted treatments, leading to better patient outcomes. The increasing demand for personalized medicine is driving the growth of the medical technology market, as healthcare providers invest in genetic testing equipment and technologies. Local special circumstances in Jordan, such as a growing population and an increasing burden of chronic diseases, are also driving the growth of the Medical Technology market. The country's population is expanding rapidly, leading to a greater demand for healthcare services and medical technology. Additionally, the prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is on the rise, creating a need for advanced medical devices and technologies to manage and treat these conditions. Underlying macroeconomic factors, such as government initiatives and investments, are also contributing to the development of the Medical Technology market in Jordan. The government has been actively promoting the adoption of digital health solutions and investing in healthcare infrastructure to improve access to quality healthcare services. These initiatives are creating a favorable environment for the growth of the medical technology market. In conclusion, the Medical Technology market in Jordan is developing in response to customer preferences for advanced healthcare solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The adoption of digital health solutions, the focus on personalized medicine, the growing population and burden of chronic diseases, and government initiatives and investments are all contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)